Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-11.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-11.4%/yr
Quarterly compound
Percentile
P86
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
PeriodValue
Q3 2025100.00%
Q2 20254.69%
Q1 20250.00%
Q4 20240.00%
Q3 2024-100.00%
Q2 2024147.84%
Q1 2024-73.29%
Q4 2023-80.91%
Q3 2023-32.53%
Q2 202381.03%
Q1 2023177.35%
Q4 2022-235.41%
Q3 2022143.76%
Q2 20220.00%
Q1 20220.00%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%